Here - American Geriatrics Society
Here - American Geriatrics Society
Here - American Geriatrics Society
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P APER<br />
A BSTRACTS<br />
ent. We hypothesize that resveratrol may be acting through SIRT-1,<br />
which in turn inhibits p53-regulated senescence. Because colon cancer<br />
is a disease whose incidence rises with age, the ability of resveratrol<br />
to inhibit senescence and the aging process in colonic mucosa will<br />
potentially have profound applicability to colon cancer prevention.<br />
P17<br />
The Role of SIRT3-dependent Autophagy in Age-Related<br />
Hearing Loss.<br />
I. Pena , F. A. Pereira. Huffington Center on Aging, Departments of<br />
Otolaryngology-HNS and Molecular & Cellular Biology, Baylor<br />
College of Medicine, Houston, TX.<br />
Supported By: <strong>American</strong> Federation for Aging Research / Medical<br />
Student Training in Aging Research Program, The Oticon<br />
Foundation / The <strong>American</strong> Academy of Otolaryngology–Head &<br />
Neck Surgery Foundation, Huffington Center on Aging–Baylor<br />
College of Medicine.<br />
Background: In 2005, the WHO estimated that 278 million people<br />
suffered moderate-to-profound hearing impairments. This number is<br />
expected to reach 900 million people by 2050, creating immense socioeconomic<br />
burdens worldwide. Age-related hearing loss (AHL), a<br />
disorder associated with accumulated cellular oxidative damage, affects<br />
more than 40% of <strong>American</strong>s over age 65. The mitochondrial<br />
deacetylase SIRT3 improves antioxidant defenses by activating isocitrate<br />
dehydrogenase 2, thereby increasing the reduced-to-oxidized glutathione<br />
ratio. Oxidative stress induces autophagy, a process by which<br />
cells degrade and recycle their contents to preserve cellular health.The<br />
precise molecular mechanisms by which cells respond to oxidative<br />
stress and induce autophagy via SIRT3 have not yet been elucidated.<br />
Methods: We investigated the role of SIRT3 in regulating autophagy<br />
in model systems. We used inner ears, brain, heart, and fibroblasts<br />
from wild type (WT), SIRT3-overexpressing, and Little<br />
mice (have 40% longer lifespan and reduced oxidative stress). Experiments<br />
included activation and inhibition of autophagy and expression<br />
of SIRT3 to determine its potential role in SIRT3-dependent<br />
protective mechanisms against cellular damage and AHL.<br />
Results: The average SIRT3 levels were increased 18% in 24-<br />
month-old WT mice and increased 628% in 24—month-old Little mice,<br />
compared to their 4-month-old littermate controls.When SIRT3 levels<br />
were depleted in WT fibroblasts using siRNA, autophagy was activated<br />
as measured by LC3-II/LC3-I ratio. After an 18- or 24-hour treatment<br />
with 100nM rapamycin, autophagy levels also increased 1.8-fold while<br />
SIRT3 levels decreased 1.37-fold.Activating autophagy by 2 or 4 hours<br />
of starvation increased activation 8.35-fold and SIRT3 levels decreased<br />
3.9-fold. Inhibiting autophagy with 50uM Wortmannin for 2 or 4 hours<br />
decreased autophagy 2.78-fold and increased SIRT3 levels 1.35-fold.<br />
Conclusion: These preliminary results suggest autophagy is<br />
linked to SIRT3: increased SIRT3 is associated with improved oxidative<br />
protection and decreased autophagy and vice versa. These findings<br />
may provide therapeutic insight into rational drug design of new<br />
medications that activate SIRT3 or autophagy for the prevention of<br />
age-related hearing loss and to improve health span.<br />
P18 Encore Presentation<br />
Lipid-depleted apolipoproteins and amyloid peptides are influenced<br />
by APOE genotype and cognitive diagnosis.<br />
A. J. Hanson, 1,2 J. L. Bayer-Carter, 1,2 P. S. Green, 1,2 T. J. Montine, 1,2<br />
L. D. Baker, 1,2 G. S. Watson, 1,2 L. M. Bonner, 2 M. Callaghan, 2<br />
J. B. Leverenz, 1,2 B. K. Walter, 2 E. C. Tsai, 1,2 C. W. Wilkinson, 1,2<br />
J. Zhang, 1 S. Craft. 1,2 1. University of Washington Medical Center,<br />
Seattle, WA; 2. GRECC, VA Puget Sound Health Care System,<br />
Seattle, WA.<br />
Supported By: T32 AG-000258-13 to Dr. Hanson, R37 AG-10880<br />
from NIA to Dr Craft, P50 AG-05136 to Dr. Montine.<br />
BACKGROUND: Sporadic Alzheimer’s disease (AD) is caused<br />
in part by decreased clearance of the Aβ amyloid breakdown products.<br />
Apolipoproteins play an important yet unclear role in Aβ peptide<br />
clearance, particularly ApoE since its E4 variant is a risk factor<br />
for AD. Work in cell culture and animal models have shown that<br />
lipid-depleted apolipoproteins are less effective at binding Aβ, and<br />
that lipoprotein-depleted (LD) fractions of Aβ peptides are more<br />
toxic to neurons. However, not much is known about the lipid states<br />
of these proteins in human CSF.<br />
METHODS: Cerebrospinal fluid (CSF) was obtained from 20<br />
participants with normal cognition (mean age 69 ± 7) and 27 with<br />
amnestic mild cognitive impairment (MCI) (mean age 67 ± 6). We determined<br />
the APOE genotype status of each participant. Lipid-depleted<br />
ApoE and ApoJ and lipoprotein-depleted Aβ peptides were<br />
separated by density gradient ultracentrifugation and levels were<br />
then measured by ELISA. Groups were compared using analysis of<br />
covariance.<br />
RESULTS: Subjects with an APOE ε4 allele (E4+) had higher<br />
lipid-depleted ApoE levels, for both normal and MCI groups<br />
(p